261 related articles for article (PubMed ID: 12707398)
21. Acute effects of peritoneal dialysis solutions in the mesenteric microcirculation.
Frajewicki V; Brod V; Kushnir D; Kohan R; Bitterman H
Transl Res; 2009 May; 153(5):249-56. PubMed ID: 19375686
[TBL] [Abstract][Full Text] [Related]
22. Effects of Conversion to a Bicarbonate/Lactate-Buffered, Neutral-pH, Low-GDP PD Regimen in Prevalent PD: A 2-Year Randomized Clinical Trial.
Farhat K; Douma CE; Ferrantelli E; Ter Wee PM; Beelen RHJ; van Ittersum FJ
Perit Dial Int; 2017; 37(3):273-282. PubMed ID: 28348100
[TBL] [Abstract][Full Text] [Related]
23. Impacts of icodextrin on integrin-mediated wound healing of peritoneal mesothelial cells.
Matsumoto M; Tamura M; Miyamoto T; Furuno Y; Kabashima N; Serino R; Shibata T; Kanegae K; Takeuchi M; Abe H; Okazaki M; Otsuji Y
Life Sci; 2012 Jun; 90(23-24):917-23. PubMed ID: 22564410
[TBL] [Abstract][Full Text] [Related]
24. The in vitro biocompatibility performance of a 25 mmol/L bicarbonate/10 mmol/L lactate-buffered peritoneal dialysis fluid.
Skoufos L; Topley N; Cooker L; Dawnay A; Millar DJ; Holmes CJ; Faict D
Kidney Int Suppl; 2003 Dec; (88):S94-9. PubMed ID: 14870882
[TBL] [Abstract][Full Text] [Related]
25. The impact of dialysis solution biocompatibility on ultrafiltration and on free water transport in rats.
Aubertin G; Choquet P; Dheu C; Constantinesco A; Ratomponirina C; Zaloszyc A; Passlick-Deetjen J; Fischbach M
Pediatr Nephrol; 2012 Jan; 27(1):131-8. PubMed ID: 21744055
[TBL] [Abstract][Full Text] [Related]
26. The clinical usefulness of peritoneal dialysis fluids with neutral pH and low glucose degradation product concentration: an open randomized prospective trial.
Choi HY; Kim DK; Lee TH; Moon SJ; Han SH; Lee JE; Kim BS; Park HC; Choi KH; Ha SK; Han DS; Lee HY
Perit Dial Int; 2008; 28(2):174-82. PubMed ID: 18332454
[TBL] [Abstract][Full Text] [Related]
27. Increased survival of mesothelial cells from the peritoneum in peritoneal dialysis fluid.
Lai KN; Ho SK; Leung J; Tang SC; Chan TM; Li FK
Cell Biol Int; 2001; 25(5):445-50. PubMed ID: 11401332
[TBL] [Abstract][Full Text] [Related]
28. Generation of TNFalpha and interleukin-6 by peritoneal macrophages after overnight dwells with bicarbonate- or lactate-buffered dialysis fluid.
Liberek T; Lichodziejewska-Niemierko M; Knopinska-Posluszny W; Schaub TP; Kirchgessner J; Passlick-Deetjen J; Rutkowski B
Perit Dial Int; 2002; 22(6):663-9. PubMed ID: 12556067
[TBL] [Abstract][Full Text] [Related]
29. Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis.
Witowski J; Topley N; Jörres A; Liberek T; Coles GA; Williams JD
Kidney Int; 1995 Jan; 47(1):282-93. PubMed ID: 7731159
[TBL] [Abstract][Full Text] [Related]
30. Biocompatibility and buffers: effect of bicarbonate-buffered peritoneal dialysis fluids on peritoneal cell function.
Jörres A; Bender TO; Finn A; Witowski J; Fröhlich S; Gahl GM; Frei U; Keck H; Passlick-Deetjen J
Kidney Int; 1998 Dec; 54(6):2184-93. PubMed ID: 9853285
[TBL] [Abstract][Full Text] [Related]
31. Effects of low glucose degradation products peritoneal dialysis fluid on the peritoneal fibrosis and vascularization in a chronic rat model.
Kim CD; Kwon HM; Park SH; Oh EJ; Kim MH; Choi SY; Choi MJ; Kim IS; Park MS; Kim YJ; Kim YL
Ther Apher Dial; 2007 Feb; 11(1):56-64. PubMed ID: 17309576
[TBL] [Abstract][Full Text] [Related]
32. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo.
Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R
Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293
[TBL] [Abstract][Full Text] [Related]
33. Increased leukocyte rolling in newly formed mesenteric vessels in the rat during peritoneal dialysis.
Zareie M; van Lambalgen AA; De Vriese AS; van Gelderop E; Lameire N; ter Wee PM; Beelen RH; van den Born J; Tangelder GJ
Perit Dial Int; 2002; 22(6):655-62. PubMed ID: 12556066
[TBL] [Abstract][Full Text] [Related]
34. The application of animal models to study the biocompatibility of bicarbonate-buffered peritoneal dialysis solutions.
ter Wee PM; Beelen RH; van den Born J
Kidney Int Suppl; 2003 Dec; (88):S75-83. PubMed ID: 14870880
[TBL] [Abstract][Full Text] [Related]
35. Analysis of peritoneal leukocyte population with different dialysis fluids.
Palomar R; López-Hoyos M; Morales P; Marín MJ; Alvarez L; Ruiz-Soto M; Rodrigo E; Fernández-Fresnedo G; Lm de Francisco A; Arias M
Clin Nephrol; 2009 Aug; 72(2):137-42. PubMed ID: 19640371
[TBL] [Abstract][Full Text] [Related]
36. Osmotic agents and buffers in peritoneal dialysis solution: monocyte cytokine release and in vitro cytotoxicity.
Plum J; Schoenicke G; Grabensee B
Am J Kidney Dis; 1997 Sep; 30(3):413-22. PubMed ID: 9292571
[TBL] [Abstract][Full Text] [Related]
37. Effects of neutral pH and low-glucose degradation product-containing peritoneal dialysis fluid on systemic markers of inflammation and endothelial dysfunction: a randomized controlled 1-year follow-up study.
Park SH; Do JY; Kim YH; Lee HY; Kim BS; Shin SK; Kim HC; Chang YK; Yang JO; Chung HC; Kim CD; Lee WK; Kim JY; Kim YL
Nephrol Dial Transplant; 2012 Mar; 27(3):1191-9. PubMed ID: 21862454
[TBL] [Abstract][Full Text] [Related]
38. In vivo and in vitro effects of amino-acid-based and bicarbonate-buffered peritoneal dialysis solutions with regard to peritoneal transport and cytokines/prostanoids dialysate concentrations.
Plum J; Fusshöller A; Schoenicke G; Busch T; Erren C; Fieseler C; Kirchgessner J; Passlick-Deetjen J; Grabensee B
Nephrol Dial Transplant; 1997 Aug; 12(8):1652-60. PubMed ID: 9269644
[TBL] [Abstract][Full Text] [Related]
39. Glucose degradation products in peritoneal dialysis fluids: do they harm?
Witowski J; Jörres A; Korybalska K; Ksiazek K; Wisniewska-Elnur J; Bender TO; Passlick-Deetjen J; Breborowicz A
Kidney Int Suppl; 2003 May; (84):S148-51. PubMed ID: 12694333
[TBL] [Abstract][Full Text] [Related]
40. Biocompatibility of a 1.1% amino acid-containing peritoneal dialysis fluid compared to a 2.27% glucose-based peritoneal dialysis fluid.
Brulez HF; Dekker HA; Oe PL; Verbeelen D; ter Wee PM; Verbrugh HA
Nephron; 1996; 74(1):26-32. PubMed ID: 8883016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
